For the design of effective antiviral strategies, understanding the fundamental steps of the virus life cycle, including virus-host interactions, is essential. We performed a virus overlay protein binding assay followed by proteomics for identification of proteins from membrane fractions of A7 (Aedes aegypti) cells, C6/36 (Aedes albopictus) cells and the midgut brush border membrane fraction of Ae. aegypti mosquito that bind to dengue-2 virus. Actin, ATP synthase β subunit, HSc 70, orisis, prohibitin, tubulin β chain, and vav-1 were identified as dengue-2-virus-binding proteins. Our results suggest that dengue-2 virus exploits an array of housekeeping proteins for its entry in mosquito cells.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00705-010-0728-7 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Identification of a dengue 2 virus envelope protein receptor in critical for viral midgut infection.
Proc Natl Acad Sci U S A
November 2024
Laboratory of Malaria and Vector Research, National Institutes of Allergy and Infectious Diseases, NIH, Rockville, MD 20852.
The establishment of a productive dengue virus (DENV) infection in the midgut epithelial cells of is critical for the viral transmission cycle. The hypothesis that DENV virions interact directly with specific mosquito midgut proteins was explored. We found that DENV serotype 2 (DENV2) pretreated with trypsin interacted with a single 31 kDa protein, identified as AAEL011180 by protein mass spectrometry.
View Article and Find Full Text PDFGenomic surveillance reveals a dengue 2 virus epidemic lineage with a marked decrease in sensitivity to Mosnodenvir.
Nat Commun
October 2024
Unité des Virus Émergents (Aix-Marseille Université, Università di Corsica, IRD 190, Inserm 1207, IRBA), Marseille, France.
Article Synopsis
- * Recent analysis of dengue virus genomes from the French Caribbean revealed a mutation (NS4B:V91A) associated with reduced sensitivity to mosnodenvir, particularly in the DENV-2 strain, where sensitivity dropped by more than 1000 times.
- * Phylogenetic analysis suggests that the low sensitivity due to the V91A mutation has re-emerged several times over the past 30 years in DENV-2 and DENV-3, highlighting the need for
Molecular epidemiology and evolutionary characteristics of dengue virus 2 in East Africa.
Nat Commun
September 2024
Department of Pediatrics, Division of Infectious Diseases, Stanford University School of Medicine, Stanford University, Stanford, CA, 94305, USA.
Despite the increasing burden of dengue, the regional emergence of the virus in Kenya has not been examined. This study investigates the genetic structure and regional spread of dengue virus-2 in Kenya. Viral RNA from acutely ill patients in Kenya was enriched and sequenced.
View Article and Find Full Text PDFCross-Neutralizing Anti-Chikungunya and Anti-Dengue 2 IgG Antibodies from Patients and BALB/c Mice against Dengue and Chikungunya Viruses.
Viruses
July 2024
Laboratorio de Medicina de Conservación de la Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City 11340, Mexico.
Dengue (DENV) and Chikungunya (CHIKV) viruses can be transmitted simultaneously by mosquitoes, and there may be co-infections in humans. However, how the adaptive immune response is modified in the host has yet to be known entirely. In this study, we analyzed the cross-reactivity and neutralizing activity of IgG antibodies against DENV and CHIKV in sera of patients from the Mexican Institute of Social Security in Veracruz, Mexico, collected in 2013 and 2015 and using IgG antibodies of BALB/c mice inoculated with DENV and/or CHIKV.
View Article and Find Full Text PDFMechanisms of Flavivirus Cross-Protection against Yellow Fever in a Mouse Model.
Viruses
May 2024
Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.
Article Synopsis
- * Researchers studied the effects of pre-existing immunity from related viruses like dengue (DENV) and Zika (ZIKV) on YFV infection using a mouse model.
- * Findings indicate that immunity from DENV-2 and ZIKV can significantly reduce YFV levels in mice, mostly through humoral immune responses, suggesting a need to reevaluate YFV outbreak risks considering existing flavivirus immunity.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!